One postdoctoral position in the field of the tumor microenvironment is available in Dr. Jing Yang's lab at Houston Methodist Cancer Center,
Houston Methodist Research Institute. The fellow is being recruited for projects aimed at identifying biomarkers for therapeutic targets in multiple myeloma. The overarching goal of Dr. Yang's translational research program is to study the mechanism underlying the pathogenesis of multiple myeloma, focusing on the interaction of tumor cells with adipocytes, and the role of bone marrow microenvironment in chemotherapy and immunotherapy. These studies aim to provide novel and potential therapeutic targets and tools for the treatment of myeloma patients. Please refer to our recent publication for more information (Science Translational Medicine 8(353):353ra113, 2016. PMID: 275590962016; Science Translational Medicine 11(494), 2019. PMID: 31142679).
We seek highly motivated, enthusiastic individuals who have a Ph.D. and/or M.D. degree with less than 2 years of postdoctoral experience in tumor biology, molecular biology, biochemistry or related fields. Any candidates with a solid background in the tumor microenvironment, tumor metabolism, tumor metastasis, and immunology are especially encouraged to apply. Applications, including curriculum vitae, contact information for three references, and a brief summary of past accomplishments should be sent by email to Dr. Jing Yang. Email: jyang2@houstonmethodist.org |